NEO New Oncology's Unattributed Round

NEO New Oncology raised a round of funding on March 17, 2015.

New Oncology's a genomic diagnostic platform enables physicians to better select targeted cancer therapies. Its offering includes assays for both tissue and bodily fluids--and it has a liquid biopsy t…

Articles about NEO New Oncology's Unattributed Round: